Publications by authors named "T Styblo"
Bilateral risk-reducing mastectomy (BRRM) is the surgical removal of both breasts to reduce the risk of cancer. In this Society of Surgical Oncology position statement, we review the literature addressing the indications, outcomes, and risks of BRRM to update the society's 2017 statement. We held a virtual meeting to outline key topics and conducted a literature search using PubMed to identify relevant articles.
View Article and Find Full Text PDFPurpose: To explore the feasibility of imaging amino-acid transport and PSMA molecular pathways in the detection of metastatic breast invasive lobular carcinoma (ILC) and if there is superior detection compared to standard-of-care imaging [computed tomography (CT)/bone scan, or F-FDG positron-emission-tomography (PET)-CT].
Methods: 20 women with de-novo or suspected metastatic ILC underwent two PET-CT scans with F-fluciclovine and Ga-PSMA-11 on separate days. Uptake per patient and in 3 regions per patient - ipsilateral axillary lymph node (LN), extra-axillary LN (ipsilateral supraclavicular or internal mammary), or distant sites of disease - was compared to standard-of-care imaging (CT/bone scan in 13 patients and F-FDG PET-CT in 7 patients).
Background: An important component of preoperative counseling and patient selection involves surgical risk stratification. There are many tools developed to predict surgical complications. The Modified Frailty Index (mFI) calculates risk based on the following five elements: hypertension, chronic obstructive pulmonary disease, congestive heart failure, diabetes, and functional status.
View Article and Find Full Text PDFImpact of Oncoplastic Surgery on Oncologic Outcomes in Patients with Breast Cancer.
Plast Reconstr Surg Glob Open
January 2024
Background: For patients with breast cancer, oncoplastic surgery (OPS) serves as a valuable technique that allows for immediate reconstruction at the time of resection. While the aim of OPS is to improve breast cosmesis, it is critical to ensure OPS does not negatively impact appropriate cancer treatment.
Methods: Based on current literature, this study provides a broad overview on the potential oncologic advantages of OPS for patients diagnosed with breast cancer.
Article Synopsis
- - Rates of contralateral mastectomy (CM) for unilateral breast cancer are rising in the U.S., with patients considering factors like the risk of contralateral breast cancer (CBC) and aesthetic concerns, while surgeons focus mainly on CBC risk.
- - Although CM can lower the risk of developing new breast cancer in high-risk patients, it hasn't been shown to improve overall survival rates.
- - Recommendations include performing mammograms within a year before CM but not routine preoperative MRIs or postoperative imaging, and it's advised that shared decision-making can help manage the rates of CM.